1/30/2025 9:28:21 AM New Policy for Compassionate Use Programs By Hester Borgers Maud van Haaren The Dutch Medicines Evaluation Board (MEB) has recently published a new policy for Compassionate Use Programmes (CUP).[1] To support the...
1/29/2025 11:15:40 AM First decision on the SPC manufacturing waiver by the Belgian courts By Domien Op de Beeck Camille Vanpeteghem On 23 December 2024, the Brussels enterprise court issued a first decision in Belgium on the so-called “SPC manufacturing waiver”. Under...
1/22/2025 11:28:54 AM EMA’s finalised reflection paper on the use of AI By Hester Borgers Maud van Haaren On 9 September 2024 the European Medicines Agency (“EMA”) issued its final reflection paper on the use of AI in the medicinal product...
1/13/2025 11:15:48 AM EMA and HMA Update Guidance on Commercially Confidential Information in Marketing Authorisation Applications By Benedicte Mourisse Marc Martens The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) have announced a significant update to their guidance on...